Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial
2010 ◽
Vol 77
(7)
◽
pp. 1012-1017
◽
2009 ◽
Vol 2
(12)
◽
pp. 1190-1198
◽
2013 ◽
Vol 166
(6)
◽
pp. 1035-1042
◽